NEW C. diff Vaccine Trial

posted Aug 6, 2013, 8:09 AM by Jennifer Aranda
Physician Care Clinical Research is now testing a NEW vaccine which directs the immune system to produce antibodies against C.diff toxins.

The objective of the Cdiffense trial is to evaluate the safety, immunogenicity and efficacy of a toxoid vaccine for the prevention of primary symptomatic Clostridium difficile Infection ( CDI).

C. diff is emerging as a leading cause of life threatening, health-care acquired infections worldwide. Unfortunately, at this time there are no licensed vaccines available that can prevent C. difficile infection.

Contact Us for more information

Comments